Essiac
secondary literature · 2022
SUMMARY
Cancer Research UK's current patient-facing monograph on Essiac, stating there is no evidence to use it as a treatment for cancer and that U.S. National Cancer Institute testing found no anti-cancer effects and no well-conducted clinical trials showing benefit. Fetched directly 2026-08-17.
NOTES
A current (2022-reviewed), major independent cancer charity’s authoritative patient-information assessment, used as one of this case’s present-day critique sources for the still-marketed product.